Funding for this research was provided by:
Krebsliga Schweiz (HSR-5217-11-2020)
Received: 30 May 2022
Accepted: 3 August 2022
First Online: 29 August 2022
: Ethics approval and consent to participate: Approved by the local ethical committee BASEC #2021-02004. Written, informed consent to participate will be obtained from all participants.
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Informed consent materials are attached as supplementary materials.
: The authors declare that they have no competing interests.